Right data for right patient—a precisionFDA NCI–CPTAC Multi-omics Mislabeling Challenge

Proteomics 0303 health sciences 03 medical and health sciences Staining and Labeling United States Food and Drug Administration Comment Humans Genomics National Cancer Institute (U.S.) United States 3. Good health
DOI: 10.1038/s41591-018-0180-x Publication Date: 2018-08-31T13:00:53Z
ABSTRACT
To address a critical roadblock that can occur in translational and clinical research, the National Cancer Institute and the Food and Drug Administration, in coordination with the DREAM Challenges, are launching the first computational challenge using multi-omics datasets to detect and correct specimen mislabeling.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (11)
CITATIONS (13)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....